Close
  • Latest News
  • Artificial Intelligence
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
Read Down
Sign in
Close
Welcome!Log into your account
Forgot your password?
Read Down
Password recovery
Recover your password
Close
Search
Logo
Logo
  • Latest News
  • Artificial Intelligence
  • Big Data and Analytics
  • Cloud
  • Networking
  • Cybersecurity
  • Applications
  • IT Management
  • Storage
  • Sponsored
  • Mobile
  • Small Business
  • Development
  • Database
  • Servers
  • Android
  • Apple
  • Innovation
  • Blogs
  • PC Hardware
  • Reviews
  • Search Engines
  • Virtualization
More
    Home Applications
    • Applications
    • Database

    Drug Companies Wont Swallow the Grid Pill

    By
    Lisa Vaas
    -
    June 16, 2005
    Share
    Facebook
    Twitter
    Linkedin

      Youd think that pharmaceutical companies would be ideal candidates for grid computing. They have a great need for high-performance computing in drug research, have vast amounts of data and are challenged by being one of the most geographically dispersed industries.

      Youd be wrong, according to a new report from The 451 Group.

      According to William Fellows, an analyst at the research firm and one of the authors of “Grid Computing: Adoption in the Pharmaceutical Sector,” the perceived wisdom of researchers is that less than half of the top 20 pharmaceutical companies are implementing grid.

      Of the ISVs that supply the sector, IBM claims to have relations with 50 percent of these companies. But as far as Fellows can discern through his research, the vast majority is “either at a very early stage or [does not have] what anybody would think of as an enterprise deployment,” he said.

      The researchers found that leaders such as Johnson & Johnson and Novartis AG are making great strides in grid adoption, moving from small grids to thousands of devices, gearing up to share infrastructure across their companies and putting enterprise IT applications onto grids.

      But, the report says, for the majority of pharmaceutical companies, the jury is still out on grid, with many companies having failed to find a compelling reason why they should adopt the technology.

      “Not one drugs been discovered using grid all the way through discovery through licensing to regulatory approval on the other end,” Fellows said. “Once use cases start to happen, it will encourage momentum. But were not as bullish on wider adoption of grid in this sector as some boosters are.”

      After discussions with pharmaceuticals, The 451 Group reported that “the vast majority” either dont see grid as offering an advantage over the technology theyre already using or are using it in limited tests or pilot projects for research and development.

      This doesnt make sense on a lot of fronts, Fellows said. For one thing, because of M&A (mergers and acquisitions) activity, the industry is more dispersed than any industry the research firm has looked at.

      Another issue is federating and aggregating data—a problem thats common to many industries and explains why ISVs such as IBM and Oracle Corp. are working hard to promote their own federation and aggregation technologies.

      “The top 10 pharmaceutical companies have this challenge where data from various programs is distributed all over the place,” Fellows said. “They need to bring it together, integrate it and have it able to be [analyzed] without regard to original format or where it needs to be stored.”

      As such, the industry could well benefit from grid in the same ways that other sectors are benefiting: by using spare computing cycles, reducing hardware costs by hooking up underutilized boxes, increasing cooperation and communication, producing additional analysis, and keeping pace with competitors through more rapid product development.

      Whats holding pharmaceuticals back? The same thing thats holding other industries back: software licensing, cultural organizational issues, data management issues, user resistance to running applications across the PCs of researchers, no recognition of a compelling application, and the perception that current distributed computing architectures are working just fine.

      /zimages/1/28571.gifClick here to read about Macrovision and Platform teaming up to fight the problem of software licensing across grids.

      Those companies may well have just cause to pause, Fellows said. For one thing, processing over wide areas without regard to where resources are located doesnt always pay off, since potential savings are offset by overhead.

      “A couple [of firms interviewed] said, We cannot and arent in a position to implement wide-area grid because of the overhead associated with doing this,” Fellows said. “Theyre geographically dispersed. They can take a job and drop it on a grid and have it spread over resources located around the world.

      “But the time it takes for those tasks to go find the right database, go find the right data set and take that pretty significant chunk of data back to where the application is, to then have it processed and resynchronized—the overhead in time and money is too costly at the moment,” he said. “So, they decided not to go ahead with wide-area deployment. That has to do with the cost of bandwidth.”

      At the heart of the resistance also may be the fact that pharmaceutical companies are managed by scientists who are more familiar with wet stuff—”test tubes with stuff in it,” as Fellows put it. “Grid and other ways of doing modeling analysis havent taken hold within organizations in a fundamental way yet,” he said.

      The key to change, Fellows said, is to have organizational champions who understand the benefits of IT positioned within the pharmaceutical and other industries.

      Its either that or luck. “Its having the infrastructure that has the right elements in place at the right time, so you can take advantage of certain desktops in certain areas and harvest the power,” Fellows said.

      /zimages/1/28571.gifCheck out eWEEK.coms for the latest database news, reviews and analysis.

      Lisa Vaas
      Lisa Vaas is News Editor/Operations for eWEEK.com and also serves as editor of the Database topic center. Since 1995, she has also been a Webcast news show anchorperson and a reporter covering the IT industry. She has focused on customer relationship management technology, IT salaries and careers, effects of the H1-B visa on the technology workforce, wireless technology, security, and, most recently, databases and the technologies that touch upon them. Her articles have appeared in eWEEK's print edition, on eWEEK.com, and in the startup IT magazine PC Connection. Prior to becoming a journalist, Vaas experienced an array of eye-opening careers, including driving a cab in Boston, photographing cranky babies in shopping malls, selling cameras, typography and computer training. She stopped a hair short of finishing an M.A. in English at the University of Massachusetts in Boston. She earned a B.S. in Communications from Emerson College. She runs two open-mic reading series in Boston and currently keeps bees in her home in Mashpee, Mass.
      Get the Free Newsletter!
      Subscribe to Daily Tech Insider for top news, trends & analysis
      This email address is invalid.
      Get the Free Newsletter!
      Subscribe to Daily Tech Insider for top news, trends & analysis
      This email address is invalid.

      MOST POPULAR ARTICLES

      Latest News

      Zeus Kerravala on Networking: Multicloud, 5G, and...

      James Maguire - December 16, 2022 0
      I spoke with Zeus Kerravala, industry analyst at ZK Research, about the rapid changes in enterprise networking, as tech advances and digital transformation prompt...
      Read more
      Applications

      Datadog President Amit Agarwal on Trends in...

      James Maguire - November 11, 2022 0
      I spoke with Amit Agarwal, President of Datadog, about infrastructure observability, from current trends to key challenges to the future of this rapidly growing...
      Read more
      Cloud

      IGEL CEO Jed Ayres on Edge and...

      James Maguire - June 14, 2022 0
      I spoke with Jed Ayres, CEO of IGEL, about the endpoint sector, and an open source OS for the cloud; we also spoke about...
      Read more
      Applications

      Kyndryl’s Nicolas Sekkaki on Handling AI and...

      James Maguire - November 9, 2022 0
      I spoke with Nicolas Sekkaki, Group Practice Leader for Applications, Data and AI at Kyndryl, about how companies can boost both their AI and...
      Read more
      IT Management

      Intuit’s Nhung Ho on AI for the...

      James Maguire - May 13, 2022 0
      I spoke with Nhung Ho, Vice President of AI at Intuit, about adoption of AI in the small and medium-sized business market, and how...
      Read more
      Logo

      eWeek has the latest technology news and analysis, buying guides, and product reviews for IT professionals and technology buyers. The site’s focus is on innovative solutions and covering in-depth technical content. eWeek stays on the cutting edge of technology news and IT trends through interviews and expert analysis. Gain insight from top innovators and thought leaders in the fields of IT, business, enterprise software, startups, and more.

      Facebook
      Linkedin
      RSS
      Twitter
      Youtube

      Advertisers

      Advertise with TechnologyAdvice on eWeek and our other IT-focused platforms.

      Advertise with Us

      Menu

      • About eWeek
      • Subscribe to our Newsletter
      • Latest News

      Our Brands

      • Privacy Policy
      • Terms
      • About
      • Contact
      • Advertise
      • Sitemap
      • California – Do Not Sell My Information

      Property of TechnologyAdvice.
      © 2022 TechnologyAdvice. All Rights Reserved

      Advertiser Disclosure: Some of the products that appear on this site are from companies from which TechnologyAdvice receives compensation. This compensation may impact how and where products appear on this site including, for example, the order in which they appear. TechnologyAdvice does not include all companies or all types of products available in the marketplace.

      ×